Healthcare
Topics also related to Healthcare:
CORRECTED-Sanofi drug Dupixent wins U.S. FDA approval to treat asthma
Oct 19 France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.
RPT-BUZZ- U.S. stocks weekly: Seeking traction
** S&P 500 swings into and out of negative territory, but ultimately ends week unchanged
UPDATE 2-AbbVie CFO Chase to retire by mid-year 2019
Oct 19 AbbVie Inc said on Friday that William Chase stepped down as chief financial officer and will retire from the company in mid-2019, and the U.S. drugmaker promoted controller, Robert Michael, to the CFO role.
UPDATE 1-USC agrees to $215 mln settlement in California gynecologist case
LOS ANGELES, Oct 19 The University of Southern California has reached a $215 million proposed settlement with former patients of a gynecologist at the school who was accused of sexual abuse, the president of the university said in a letter on Friday seen by Reuters.
USC agrees to $215 mln settlement in California gynecologist case
LOS ANGELES, Oct 19 The University of Southern California has reached a $215 million proposed settlement with former patients of a gynecologist at the school who was accused of sexual abuse, the president of the university said in a letter on Friday seen by Reuters.
| Healthcare | ||
| Johnson & Johnson | $139.05 | -0.32% |
| Pfizer Inc | $44.50 | +1.14% |
| UnitedHealth Group Inc | $265.30 | -0.57% |
Markets
- U.S.
- Europe
- Asia
- Sectors
| DOW | 25,444.34 |
+
64.89 |
+0.26% |
| S&P 500 | 2,767.78 |
-1.00 |
-0.04% |
| NASDAQ | 7,449.03 |
-36.11 |
-0.48% |
| TR US Index | 244.74 |
-0.42 |
-0.17% |
Sector Summary
| Energy |
-0.17%
|
| Basic Materials |
-0.76%
|
| Industrials |
-0.67%
|
| Cyclical Goods & Services |
-0.68%
|
| Non-Cyclical Goods & Services |
+1.68%
|
| Financials |
+0.08%
|
| Healthcare |
-0.78%
|
| Technology |
-0.38%
|
| Telecoms |
+0.33%
|
| Utilities |
+1.40%
|
Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.